Republicans Weigh Roger Marshall for FDA as Overton Faces Senate Vote With 6 Weeks Left
Updated
Updated · Semafor · Nov 17
Republicans Weigh Roger Marshall for FDA as Overton Faces Senate Vote With 6 Weeks Left
3 articles · Updated · Semafor · Nov 17
Summary
Roger Marshall is emerging as a fallback FDA nominee as Republicans privately concede Heidi Overton’s path to confirmation is increasingly difficult ahead of a Senate health committee vote Wednesday.
Overton has drawn opposition from both anti-abortion activists and moderate Republicans, pushing GOP lawmakers toward Marshall, a Kansas senator and physician seen as easier to confirm.
Republicans have only about six weeks left in the majority to move Trump nominees, creating pressure to decide quickly whether to stick with Overton or pivot to another candidate.
The FDA has lacked a permanent commissioner since Marty Makary was forced out in May, and acting chief Kyle Diamantas is also expected to leave rather than seek the job permanently.